Loading current stock analysis…
Loading current stock analysis…
India
Reported ownership for FY2027-Q1 as of 2026-06-30.
As of 06 Nov 2026, 03:30 pm
Global CEO Mohit Malhotra is resigning effective November 13, 2026, concluding a nearly three-decade tenure. Herjit Singh Bhalla, currently the India business CEO, has been appointed as an additional and whole-time director for a five-year term starting November 14, subject to regulatory clearances. He will continue leading the domestic growth agenda while PD Narang provides strategic guidance across international operations.
Dabur reported an 11.7% year-on-year increase in consolidated net profit to ₹505.5 crore for the July-September quarter '26. This growth was driven by premium brand outperformance and international expansion. The results were reported on November 4, 2026, alongside other major companies like Nykaa and Torrent Power.
Dabur India has declared an interim dividend of ₹3.50 per share. The record date for this payout is November 10, 2026. Shareholders must be on the company's register of members on this date to be eligible for the dividend payment.
As of November 6, 2026, the daily trend is bullish with the stock closing at ₹380.35. However, the weekly and monthly trends remain bearish. Key resistance levels are seen at ₹390.68 and ₹393.60, while immediate support lies near ₹378.52. The stock has faced significant volatility, with a current drawdown of -31.2% from its peak.
As of 06 Nov 2026, 03:30 pm
Recent drawdown or price variability is materially high and may lead to larger short-term outcomes.
Primary driver: Price remains materially below a previous peak
The session opened materially below the previous close, indicating a sharp repricing at the open.
The price gap may increase short-term downside uncertainty and warrants review of the underlying context.
Trading activity was substantially higher than usual and the price closed lower.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Trading activity was substantially higher than usual and the price closed lower.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Trading activity was substantially higher than usual and the price closed higher.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Latest complete financial results for Q2 FY27 and comparative quarterly trends.
| Metric | Q2 FY26 | Q1 FY27 | Q2 FY27(Latest) |
|---|---|---|---|
| Revenue From Operations | ₹3,191 crore | PEAK₹3,764 crore | ₹3,563 crore |
| Expenses | ₹2,758 crore | PEAK₹3,181 crore | ₹3,089 crore |
| Profit Before Exceptional Items And Tax | ₹573 crore | PEAK₹756 crore | ₹646 crore |
| Tax Expense | ₹128 crore | PEAK₹169 crore | ₹147 crore |
| Profit Loss For Period | ₹445 crore | PEAK₹586 crore | ₹499 crore |
Dabur reported Q2 FY2026-27 revenue from operations of ₹3,563 crore, up 11.6% year on year but down 5.3% from Q1 FY2026-27. Profit before tax was ₹646 crore, 12.7% above the year-earlier quarter and 14.6% below the preceding quarter; profit for the period was ₹499 crore.
Inventories were ₹2,385 crore at 30 September 2026, compared with ₹2,322 crore at 31 March 2026. Trade receivables increased to ₹1,060 crore from ₹715 crore, while current trade payables rose to ₹3,045 crore from ₹2,954 crore.
Current borrowings increased to ₹1,236 crore from ₹1,047 crore at 31 March 2026. Non-current borrowings were ₹6 crore, down from ₹16 crore at the previous fiscal year-end.
Total assets were ₹17,869 crore at 30 September 2026, up from ₹17,480 crore at 31 March 2026. Equity attributable to owners of the parent was ₹11,492 crore, compared with ₹11,420 crore at the fiscal year-end; total equity was ₹11,864 crore.
Dabur’s Q2 showed year-on-year growth in revenue and profit, alongside a sequential pullback from Q1. Expenses fell less than revenue quarter on quarter, while operating cash flow remained positive; higher current borrowings and receivables, together with lower cash and current investments than at 31 March, are notable balance-sheet movements.
Exchange disclosures and regulatory announcements for Dabur India.
SERIES:EQ |PURPOSE:INTERIM DIVIDEND - RS 3.50 PER SHARE |FACE VALUE:1 |RECORD DATE:10-Nov-2026 |BOOK CLOSURE START DATE:- |BOOK CLOSURE END DATE:-
SERIES:EQ |PURPOSE:INTERIM DIVIDEND - RS 3.50 PER SHARE |FACE VALUE:1 |RECORD DATE:10-Nov-2026 |BOOK CLOSURE START DATE:- |BOOK CLOSURE END DATE:-
Dabur India Limited has informed the Exchange about Audio Recording/Video Recording |SUBJECT: Analyst/Investor Meet Para A-XBRL
SERIES:EQ |PURPOSE:INTERIM DIVIDEND - RS 3.50 PER SHARE |FACE VALUE:1 |RECORD DATE:10-Nov-2026 |BOOK CLOSURE START DATE:- |BOOK CLOSURE END DATE:-
On November 6, 2026, Dabur India Limited’s Nomination & Remuneration Committee approved allotment of 107,691 equity shares of ₹1 each under the Dabur Employees Stock Option Scheme 2000, following employees’ exercise of options. The allotment increased paid-up equity share capital from ₹177,39,57,506, comprising 177,39,57,506 shares, to ₹177,40,65,197, comprising 177,40,65,197 shares. The new shares rank pari passu with existing equity shares.
Dabur India Limited (NSE: DABUR) informed the NSE on November 6, 2026, regarding the allotment of equity shares under its Employee Stock Option Plan (ESOP). The allotment increased the paid-up share capital from INR 1,773,957,506 to INR 1,774,065,197, representing an issuance of 107,691 shares. The company stated that prior disclosure under SEBI LODR and Circular dated September 9, 2015, was not applicable because the ESOP plan was originally approved by the Board on July 31, 2000.
Dabur India Limited informed the National Stock Exchange and Bombay Stock Exchange on November 6, 2026, that it received an administrative warning letter from the Securities and Exchange Board of India (SEBI). The warning cites a violation of Regulation 30 read with sub-para 20 of Para A Part A Schedule III of SEBI (LODR) Regulations due to delayed disclosure of a US FDA warning letter dated July 24, 2026. SEBI advised the company and its Board to avoid future lapses, noting that any repetition will be viewed seriously. Dabur stated there is no impact on financial operations and pledged to take necessary steps to address the concern.
Dabur India Limited disclosed on November 6, 2026, that it received an Administrative Warning and advice letter from the Securities and Exchange Board of India (SEBI). The regulatory action cites a violation of Regulation 30(6)(iii) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, due to a delay in disclosing a warning letter previously received from the US FDA on July 24, 2026. SEBI directed the company to exercise caution to avoid recurrence of such disclosure lapses. The company stated there is no impact on its financial operations and committed to taking necessary steps to address the directive.
Recent market and company developments associated with Dabur India.
Motilal Oswal has assigned a neutral rating to Dabur, setting a price target of Rs 425 for the stock. This recommendation was published on November 7, 2026.
At least 75 companies, including Dabur India, HUL, ONGC, and RITES, have fixed record dates for dividend, bonus, or rights issues between November 9 and 13, 2026. Dharti Proteins is the sole entity among these firms with a bonus issue record date on November 13, following its board's approval of a 1:1 ratio. Investors must hold shares before the respective record dates to qualify for these corporate actions.
More than 50 stocks and investment trusts are scheduled to trade ex-date next week for various corporate actions, including dividends, rights issues, and share buybacks. The combined value of the 51 announced dividend entries totals ₹315.21 per share, with Bayer CropScience declaring the highest individual payout at ₹90 per share.
Dabur India has appointed India business CEO Herjit Singh Bhalla as an additional and whole-time director for a five-year term starting November 14, subject to regulatory clearances. This appointment coincides with the departure of Global CEO Mohit Malhotra after nearly three decades, while other board-level changes include the addition of Gopal Krishna Jain and a succession in the compliance function.
Indian equity benchmarks extended their winning streak to a fifth consecutive session, with the Nifty 50 closing at 23,961 amid broad-based buying and optimism for a breakout above 24,000. Several companies, including BSE, Lenskart, Nykaa, Bharti Airtel, LIC, Aurobindo Pharma, and NALCO, are in focus as investors track their September-quarter earnings, sales data, and operational updates. Experts advise monitoring support levels around 23,750–23,700 as the bullish trend persists.
Dabur India announced the resignation of Global CEO Mohit Malhotra, effective November 13, 2026, as part of continued leadership churn in legacy FMCG companies amid uneven demand and intense competition. Herjit Singh Bhalla has been appointed as additional director and whole-time director for a five-year period to succeed him. This transition occurs while Dabur reported an 11.7% year-on-year increase in consolidated net profit to Rs 505.5 crore for the July-September quarter '26, driven by premium brand outperformance and international growth.
Dabur India announced that Global CEO Mohit Malhotra is stepping down effective November 13 to pursue personal interests, concluding a three-decade tenure. Herjit S Bhalla, currently the Chief Executive Officer of the India business, has been elevated to the board as a Whole-time Director for five years starting November 14, while continuing to lead the domestic growth agenda. PD Narang will remain as Group Director – Corporate Affairs to provide strategic guidance across the group's businesses, including international operations.
Multiple companies including Dabur, Nykaa, Torrent Power, Apollo Hospitals, and BSE reported their Q2 results on November 4, with most posting double-digit profit growth. While entities like Apollo Tyres and RITES saw earnings declines or margin contractions, others such as PhysicsWallah and Chalet Hotels demonstrated significant improvements in profitability metrics despite varying revenue trends.
Comprehensive Section Breakdown for Dabur India
Strategic Vision: Herbal and natural products company integrating traditional knowledge with modern science.
• Heritage spanning over 138 years
• Extensive product portfolio of over 250 products
• Robust distribution network exceeding 7.7 million retail outlets
• Integration of traditional Ayurvedic knowledge with modern science
Revenue from operations increased from ₹3,191 crore in Q2 FY2025-26 to ₹3,563 crore in Q2 FY2026-27. Sequentially, it eased from ₹3,764 crore in Q1 FY2026-27. The quarterly series was ₹3,038 crore in Q4 FY2025-26 and ₹3,559 crore in Q3 FY2026-27 before reaching ₹3,764 crore in Q1 FY2026-27.
Total expenses were ₹3,089 crore, down 2.9% from ₹3,181 crore in Q1 FY2026-27 but up 12.0% from ₹2,758 crore in Q2 FY2025-26. On a sequential basis, expenses declined less than revenue, accompanying the fall in profit before tax. Income, including other income of ₹172 crore, was ₹3,735 crore, down 5.1% from Q1 FY2026-27.
Q2 expenses included ₹1,443 crore for materials consumed, ₹317 crore for purchases of stock in trade, ₹377 crore in employee benefit expense and ₹119 crore in depreciation, depletion and amortisation.
Profit before tax was ₹646 crore, compared with ₹756 crore in Q1 FY2026-27 and ₹573 crore in Q2 FY2025-26. Tax expense totalled ₹147 crore, comprising current tax of ₹155 crore and a deferred tax credit of ₹8 crore. Profit from continuing operations was ₹499 crore, down 15.0% sequentially and up 12.1% year on year.
Basic EPS from continuing operations was ₹2.85, versus ₹3.33 in Q1 FY2026-27 and ₹2.55 in Q2 FY2025-26. Diluted EPS was ₹2.84. Trailing twelve-month EPS was ₹11.42.
Operating cash flow was ₹709 crore in the quarter. Reported free cash flow was ₹848 crore, while investing cash flow was positive ₹138 crore. Financing cash flow was negative ₹973 crore, indicating a net cash outflow from financing activities.
At 30 September 2026, cash and cash equivalents were ₹133 crore and other bank balances were ₹425 crore. Current investments stood at ₹4,374 crore, down from ₹4,595 crore at 31 March 2026. The quarter-end investment balance remained substantially higher than cash and cash equivalents.
Category: Consumer Goods
Offers a range of healthcare products rooted in Ayurvedic principles and modern science.
Key Products & Services: Dabur Chyawanprash
Category: Consumer Goods
Provides personal care items, including skincare and hair care products, often leveraging natural ingredients.
Key Products & Services: Dabur Amla • Siens by Dabur • Sesa Care
Category: Consumer Goods
Includes food and beverage products, with a focus on natural and traditional offerings.
Key Products & Services: Vevek Ethnic Foods Pvt. Ltd. • Warana Dairy and Agro Industries Limited • Schreiber Dynamix Dairies Private Limited
Core Thesis: Integrates traditional Ayurvedic knowledge with modern science to develop efficacious products for global consumers.
• Product Innovation: Develops efficacious products by integrating traditional knowledge with modern science, launching new brands and product enhancements. • Brand Legacy: Leverages a heritage of over 138 years and well-established brands like Dabur Chyawanprash and Dabur Amla. • Global Reach: Reaches consumers through a robust network in over 120 countries. • Strategic Investments: Establishes funds like Dabur Ventures to invest in consumer-centric startups and foster innovation.